Endocrine Abstracts

Background: Dose adjustment for normal eating (DAFNE) structured education programme is an effective tool in improving glycaemic control in patients with type 1 diabetes while reducing the frequency of hypoglycemic episodes. DAFNE however, does not solve all glucose related problems and patients often request or are recommended continuous subcutaneous insulin infusion (CSII) therapy post DAFNE.Objective: Out of our 370 DAFNE graduates, 46 have subsequent...

Background: There are very few studies comparing glycaemic control in patients with different basal rates on Continuous Subcutaneous Insulin Infusion therapy (CSII), so the ideal number of basal rates for a patient is not clear.Objective: To compare the glycaemic control between patients with different basal rates.Methods: Data were collected from hospital’s database and by contacting patients via phone....

Background: The leading cause of visual impairment among individuals with diabetes is diabetic retinopathy. Hybrid closed-loop (HCL) therapy has revolutionised diabetes care, offering a more automated and precise approach to insulin delivery. However, these technologies can inadvertently marginalise individuals with disabilities, including those with visual impairment.Case: We present the case of a legally blind 70-year-old female with a 60-year history ...